Articles Published in 2013

Meda acquires Acton Pharmaceuticals

Friday, August 30, 2013 02:27 PM

Meda, an international specialty pharmaceutical company, has acquired Acton Pharmaceuticals for $135 million, plus a milestone payment of $10 million and royalties. The acquisition is expected to close during the fourth quarter and is subject to customary closing conditions and U.S. regulatory approval. Existing credit facilities will fund the acquisition.

More... »

Bosch Healthcare, Remedy Health Media partner to enhance patient engagement

Friday, August 30, 2013 02:26 PM

Robert Bosch Healthcare Systems, a provider of telehealth systems, and Remedy Health Media, a provider of clinical resources and wellness tools, have partnered to develop and market a suite of web-based products and solutions focused on supporting better patient engagement in telehealth and compliance with medical care. The partnership combines Bosch’s evidence-based telehealth solutions for chronic medical and mental health conditions with Remedy’s design and development of patient engagement models to improve patients’ compliance with medical care and self-management skills.

More... »

Idera Pharmaceuticals, NCI collaborate

Friday, August 30, 2013 02:25 PM

Idera Pharmaceuticals entered into a Materials Cooperative Research and Development Agreement (M-CRADA) with the National Cancer Institute (NCI) to evaluate the company’s Toll-like receptor (TLR) antagonists as a potential approach to the treatment of certain genetically defined B-cell lymphomas.

More... »

Humana, Lilly collaborate to improve healthcare outcomes

Friday, August 30, 2013 02:24 PM

Humana, a Louisville, Ky.-based health and well-being company, and Eli Lilly have signed a multi-year collaboration to improve the healthcare of their members and patients.

More... »

ObsEva, Merck Serono ink license agreement

Friday, August 30, 2013 02:23 PM

ObsEva, a Swiss-based, specialty biopharmaceutical company, signed a licensing agreement with Merck Serono, the biopharmaceutical division of Germany-based Merck, granting ObsEva worldwide development and commercialization rights to certain Merck Serono compounds for preterm labor. The details of the agreement were not disclosed. The funding will allow ObsEva to undertake the development of these compounds.

More... »

International Stem Cell, Duke collaborate on Parkinson's disease

Friday, August 30, 2013 02:22 PM

International Stem Cell (ISCO), a California-based biotechnology company developing novel stem cell-based therapies, has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's neural stem cell product.

More... »

Zealand, Eli Lilly collaborate on peptide drug R&D

Friday, August 30, 2013 02:20 PM

Zealand Pharma, a Denmark-based biotechnology company, announced an exclusive peptide drug R&D collaboration with Eli Lilly.

More... »

OPKO acquires Prolor Biotech

Friday, August 30, 2013 02:19 PM

OPKO Health, a multinational biopharmaceutical and diagnostics company, has acquired Prolor Biotech, a clinical-stage biopharmaceutical company. Stockholders of Prolor will receive 0.9951 shares of OPKO common stock for each share of Prolor common stock. The stockholders of both companies approved all proposals presented at their respective stockholder meetings.

More... »

Quintiles receives Computerworld Data+ Editor's Choice Award

Thursday, August 29, 2013 01:00 PM

CRO Quintiles has been recognized for its pioneering work creating big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process, with a Computerworld Data+ Editor's Choice Award for its Quintiles Infosario platform.

More... »

Rho awarded for workplace effectiveness, flexibility

Thursday, August 29, 2013 12:00 PM

CRO Rho has received the 2013 Alfred P. Sloan Award for Excellence in Workplace Effectiveness and Flexibility. 

More... »